Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts

Canadian Journal of Cardiology

Volumn 12, Issue 10, 1996, Pages 1099-1104

  Anderson, B ^a   Khaper, N ^a   Dhalla, Arvinder K ^a   Singal, Pawan K ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

ACE inhibition; Antioxidants; Cardiac failure; Lipid peroxidation

Indexed keywords

ANTIOXIDANT; CAPTOPRIL; CATALASE; ENALAPRIL; ENZYME; FREE RADICAL; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; ISOLATED HEART; LIPID PEROXIDATION; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; CATALASE; ENALAPRIL; FREE RADICALS; GLUTATHIONE PEROXIDASE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 0029820307     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ziegelhoffer A, Das PK, Sharma GP, Singal PK, Dhalla NS. Propranolol effects on myocardial ultrastructure and high energy phosphates in anesthetized dogs subjected to ischemia and reperfusion. Can J Physiol Pharmacol 1979;57:977-86.
2. Hearse DJ, Manning AS, Downey JM, Yellon DM. Xanthine oxidase: A critical mediator of myocardial injury during ischemia and reperfusion. Acta Physiol Scand 1986;548(Suppl):65-78.
3. Dhalla NS, Pierce GN, Panagia V, Singal PK, Beamish RE. Calcium movements in relation to heart function. Basic Res Cardiol 1982;77:117-39.
4. Steenbergen CE, Murphy LL, London RE. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 1987;60:700-7.
5. Freeman BA, Crapo MD. Biology of disease. Free radicals and tissue injury. Lab Invest 1982,47:412-26.
6. Ferrari R, Ceconi C, Curello S, et al. Oxygen mediated myocardial damage during ischemia and reperfusion. Role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol 1985;17:937-45.
7. Bolli R, Patel BS, Jeroudi MO, Lai EK, MaCay PB. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap α-phenyl N-Tert-butyl nitrone. J Clin Invest 1988;82:476-85.
8. Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK. Free radicals and the heart. J Pharmacol Toxicol Meth 1993;30:55-67.
9. Dhaliwal H, Kirshenbaum LA, Randhawa AK, Singal PK. Correlation between antioxidant changes during hypoxia and recovery upon reoxygenation.Am J Physiol 1991;261 (Heart Circ Physiol 30): H632-8.
10. Kirshenbaum LA, Singal PK. Changes in antioxidant enzymes in isolated cardiac myocytes subjected to hypoxia-reoxygenation. Lab Invest 1992;67:796-806.
11. Przyklenk K, Kloner RA. Superoxide dismutase plus catalase improve contractile function in the canine model of the stunned myocardium. Circ Res 1986;58:148-56.
12. Bolli R, Jeroudi MO, Patel BS. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Circulation 1989;65:607-22.
13. Romankiewicz JA, Brogden RN, Heel RC, Speight TM, Avery GS. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure. Drugs 1983;25:6-40.
14. Unger T, Gohlke P. Converting enzyme inhibitors in cardiovascular therapy: current status and future potential. Cardiovasc Res 1994;28:146-58.
15. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985a;57:84-95.
16. Pfeffer MA, Pfeffer JM, Steinberg C, Jinn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985b;72:406-12.
17. Westlin W, Mullane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation 1988;77(Suppl 1):130-9.
18. Przyklenk K, Whittaker P, Kloner RA. Zofenopril, a newly developed sulphydryl-containing angiotensin converting enzyme inhibitor, enhances contractile function of "stunned" myocardium. In: MacGregor GA, Sever PS, eds. Current Advances in ACE Inhibition. London: Churchill Livingstone, 1989:279.
19. van Gilst WH, de Graeff PA, Wesseling H, de Langen CD. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril and HOE 498. J Cardio Pharmacol 1986;8:722-8.
20. Przyklenk K, Kloner RA. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action. Am Heart J 1991;121:1319-30.
21. Pi X, Chen XJ. Captopril and ramipril protect against free radical injury in isolated working rat hearts. J Mol Cell Cardiol 1989;21:1261-71.
22. Engleman RM, Rousou JA, Iyengar J, Das DK. Captopril, an ACE inhibitor for optimizing reperfusion after acute myocardial infarction. Ann Thorac Surg 1991;52:918-26.
23. Chopra M, Beswick H, Clapperton M, Dargie HJ, Smith WE, McMurray J. Antioxidant effects of angiotensin converting enzyme (ACE) inhibitors: free radicals and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl and non-sulfhydryl containing ACE inhibitors. J Cardiovasc Pharmacol 1992;19:330-40.
24. Slezak J, Tribulova N, Pristacova J, et al. Hydrogen peroxide changes in ischemic and reperfused heart: Cytochemistry, biochemical and X-ray microanalysis. Am J Pathol 1995;147:772-81.
25. Marklund SL. Pyrogallol autoxidation. In: Greenwald RA, ed. Handbook of Methods for Oxygen. Radical Research. Boca Raton: CRC Press, 1985:243-7.
26. Paglia DE, Valentine WN. Studies on the quantitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
27. Clairborne A. Catalase activity. In: Greenwald RA, ed. Handbook of Methods for Oxygen Radical Research. Boca Raton: CRC Press, 1985:282-4.
28. ++ binding and lipid peroxidation but depresses myocardial function. Am J Physiol 1986;250:H419-25.
29. Aust SD. Lipid peroxidation. In: Greenwald RA, ed. Handbook of Methods for Oxygen Radical Research. Boca Raton: CRC Press, 1985;203-7.
30. Lowry OH, Rosenbrough NT, Farr AL, Randall AT. Protein measurements with the folin phenol reagent. J Biol Chem 1951;193;265-75.
31. Li K, Chen X. Protective effects of captopril and enalapril on myocardial ishemia and reperfusion damage of rat. J Mol Cell Cardiol 1987;19;909-15.
32. Menasche P, Grousset C, Peynet J, Mouas C, Bloch G, Piwnica A. Pretreatment with captopril improves myocardial recovery after cardioplegic arrest. J Cardio Pharmacol 1992;19:402-7.
33. Chopra M, Scott N, McMurray J, et al. Captopril: a free radical scavenger. Br J Clin Pharmac 1989;27:396-99.
34. Cadenas E, Sies H. Low level chemiluminescence of liver microsomal fractions initiated by tert-butyl hydroperoxide. Relation to microsomal hemeproteins, oxygen dependence and lipid peroxidation. Eur J Biochem 1982;124:349-56.
35. McCord JM. Oxygen-derived free radicals in post-ischemic tissue injury. N Eng J Med 1985;312:159-63.
36. Burton KP. Superoxide dismutase enhances recovery following myocardial ischemia. Am J Physiol 1985;248 (Heart Circ Physiol):H637-43.
37. Guarnieri C, Flamigni F, Caldarera CM. Role of oxygen in cellular damage induced by reoxygenation of hypoxic heart. J Mol Cell Cardiol 1980;12:797-808.
38. Gupta M, Singal PK. Time course of structure, function, and metabolic changes due to an exogenous source of oxygen metabolites in rat heart. Can J Physiol Pharmacol 1989;67:1549-59.
39. Werns SW, Lucchesi BR. The role of the polymorphonuclear leucocyte in mediating myocardial reperfusion injury. In: Singal PK, ed. Oxygen Radicals in Pathophysiology of Heart Disease. Boston: Kluwer Academic Press 1988:123-44.
40. Kirshenbaum LA, Singal PK. Increase in endogenous antioxidant enzymes protects hearts against reperfusion injury. Am J Physiol 1993;265 (Heart Circ Physiol 34):H484-93.
41. Singal PK, Kapur N, Beamish RE, Das PK, Dhalla NS. Antioxidant protection against epinephrine-induced arrhythmias. In: Beamish RE, Singal PK, Dhalla NS, eds. Stress and Heart Disease. Boston: Martinus Nijhoff Pub, 1985:190-201.
42. Cushman DW, Wang FL, Fung WC, et al. Comparison in vitro, ex vivo and in in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Br J Clin Pharmacol 1989;28:115S-31S.
43. Grover GJ, Sleph PG, Dzwonczyk S, et al. Effects of different angiotensin-converting enzyme (ACE) inhibitors of ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection. J Pharma Exp Ther 1991;257:919-29.